These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 404834)

  • 1. [Spinocerebellar atrophy and cerebellar calcification in a case of central neurofibromatosis (author's transl)].
    Pilz P
    Acta Neuropathol; 1977 Apr; 38(1):73-6. PubMed ID: 404834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron in the Hallervorden-Spatz syndrome.
    Koeppen AH; Dickson AC
    Pediatr Neurol; 2001 Aug; 25(2):148-55. PubMed ID: 11551745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallervorden-Spatz syndrome restricted to the pallidal nuclei.
    Kessler C; Schwechheimer K; Reuther R; Born JA
    J Neurol; 1984; 231(3):112-6. PubMed ID: 6481416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hallervorden-Spatz disease with bilateral involvement of globus pallidus and substantia nigra: MR demonstration.
    Porter-Grenn L; Silbergleit R; Mehta BA
    J Comput Assist Tomogr; 1993; 17(6):961-3. PubMed ID: 8227584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism.
    Jankovic J; Kirkpatrick JB; Blomquist KA; Langlais PJ; Bird ED
    Neurology; 1985 Feb; 35(2):227-34. PubMed ID: 3969211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic late-onset Hallervorden-Spatz disease presenting as parkinsonism in a Chinese patient.
    Wang LN; Huang KW; Liu ZY
    Chin Med J (Engl); 1990 Aug; 103(8):686-8. PubMed ID: 2122948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Hallervorden-Spatz Disease].
    Seitelberger F
    Nervenarzt; 1966 Nov; 37(11):482-93. PubMed ID: 5983175
    [No Abstract]   [Full Text] [Related]  

  • 8. Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: a case of akinesia as a predominant feature of parkinsonism.
    Yamamoto T; Kawamura J; Hashimoto S; Nakamura M; Iwamoto H; Kobashi Y; Ichijima K
    J Neurol Sci; 1991 Jan; 101(1):98-106. PubMed ID: 1709202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebellar atrophy associated with lesions of the pallidum and luys' body and presence of lewy bodies. Relationships with degenerative disorders of the pallidum, substantia nigra and luys' body (author's transl)].
    Morin P; Lechevalier B; Bianco C
    Rev Neurol (Paris); 1980; 136(5):381-90. PubMed ID: 7466122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hallervorden-Spatz disease with Lewy bodies].
    Antoine JC; Tommasi M; Chalumeau A; Jouvet-Telinge A; Bourrat C
    Rev Neurol (Paris); 1985; 141(12):806-9. PubMed ID: 3008295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical dopa responsive parkinsonism in a patient with megalencephaly, midbrain Lewy body disease, and some pathological features of Hallervorden-Spatz disease.
    Tuite PJ; Provias JP; Lang AE
    J Neurol Neurosurg Psychiatry; 1996 Nov; 61(5):523-7. PubMed ID: 8937352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology and nosology.
    Defendini R; Markesbery WR; Mastri AR; Duffy PE
    J Neurol Sci; 1973 Sep; 20(1):7-23. PubMed ID: 4355342
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case of parkinsonism with degeneration of the outer globus pallidus--relationship to progressive atrophy of globus pallidus and Hallervorden-Spatz disease].
    Harada K; Koike M; Tomonaga M
    Rinsho Shinkeigaku; 1972 Jul; 12(7):339-45. PubMed ID: 4674768
    [No Abstract]   [Full Text] [Related]  

  • 14. Hallervorden-Spatz syndrome.
    Dooling EC; Schoene WC; Richardson EP
    Arch Neurol; 1974 Jan; 30(1):70-83. PubMed ID: 4808495
    [No Abstract]   [Full Text] [Related]  

  • 15. [Importance of magnetic resonance in the diagnosis of Hallervorden- Spatz disease: presentation of a case with familial history].
    Pérez Sempere A; Martínez Menéndez B; Villaverde Amundarain FJ; Calandre Hoenigsfeld L; Bermejo Pareja F
    Neurologia; 1990; 5(7):252-3. PubMed ID: 2288756
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis of pigment and spheroid formation in Hallervorden-Spatz syndrome and related disorders.
    Park BE; Netsky MG; Betsill WL
    Neurology; 1975 Dec; 25(12):1172-8. PubMed ID: 1238961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallervorden-Spatz disease. Late infantile and adult types, report of two cases.
    Rozdilsky B; Cumings JN; Huston AF
    Acta Neuropathol; 1968 Jan; 10(1):1-16. PubMed ID: 5640114
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hallervorden-Spatz disease].
    Ohno M; Goto I
    Nihon Rinsho; 1993 Nov; 51(11):2957-61. PubMed ID: 8277577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hallervorden Spatz disease. Its pathogenesis and place among the axonal dystrophies.
    Sacks OW; Aguilar MJ; Borwn WJ
    Acta Neuropathol; 1966 Mar; 6(2):164-74. PubMed ID: 5963287
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myoclonic form of Hallervorden-Spatz disease. Clinical aspect simulating a subacute spongiform encephalitis].
    Radermecker J; Rizzuto N
    Rev Neurol (Paris); 1967 Feb; 116(2):184-8. PubMed ID: 6047744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.